Skip to main content
Log in

Transplantation

Desensitization and survival in kidney transplant recipients

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

Elimination of donor-specific antibodies against HLA has been used to enable transplantation of HLA-incompatible kidneys from living donors. In contrast to two previous US studies, a UK study now reports that desensitization does not offer a survival benefit over remaining on the waitlist for a compatible organ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Opelz, G. President's address. The Transplantation Society — Berlin 2012. Transplantation 95, 4–7 (2013).

    Article  Google Scholar 

  2. Manook, M. et al. Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis. Lancet http://dx.doi.org/10.1016/S0140-6736(16)31595-1 (2017).

  3. Süsal, C. et al. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics. Tissue Antigens 86, 317–323 (2015).

    Article  Google Scholar 

  4. Süsal, C. & Morath, C. Current approaches to the management of highly sensitized kidney transplant patients. Tissue Antigens 77, 177–186 (2011).

    Article  Google Scholar 

  5. Montgomery, R. A. et al. Desensitization in HLA-incompatible kidney recipients and survival. N. Engl. J. Med. 365, 318–326 (2011).

    Article  CAS  Google Scholar 

  6. Orandi, B. J. et al. Survival benefit with kidney transplants from HLA-incompatible live donors. N. Engl. J. Med. 374, 940–950 (2016).

    Article  CAS  Google Scholar 

  7. Bentall, A. et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am. J. Transplant. 13, 76–85 (2013).

    Article  CAS  Google Scholar 

  8. Gondos, A., Döhler, B., Brenner, H. & Opelz, G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 95, 267–274 (2013).

    Article  Google Scholar 

  9. Süsal, C. et al. Donor-specific antibodies require preactivated immune system to harm renal transplant. EBioMedicine 9, 366–371 (2016).

    Article  Google Scholar 

  10. Opelz, G. et al. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation 99, 400–404 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr Undine Samuel from the Eurotransplant Foundation, Leiden, Netherlands and Dr Abdullah Sakarcan from Reading, Pennsylvania, USA, for useful information on sensitized patients in the Eurotransplant region and the USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caner Süsal.

Ethics declarations

Competing interests

C.S. has received lecture fees from Fresenius and Miltenyi, who produce immunoadsorption devices for desensitization. G.O. declares no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Süsal, C., Opelz, G. Desensitization and survival in kidney transplant recipients. Nat Rev Nephrol 13, 196–198 (2017). https://doi.org/10.1038/nrneph.2017.24

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2017.24

  • Springer Nature Limited

Navigation